Zimmer Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 6, 2001, details the immediate post-separation activities of Zimmer Holdings, Inc. following its distribution as a tax-free dividend from Bristol-Myers Squibb Company. The report covers the appointment of a new independent board of directors, the establishment of a standalone credit facility, the adoption of employee benefit plans, and adjustments to executive option awards.
Key Financial Metrics and Liquidity
The filing does not provide historical revenue, profit, or cash flow statements. Financial data is limited to the establishment of new debt facilities and projected capitalization:
- Credit Facility: Entered into a $600 million three-year competitive advance and revolving credit facility on July 31, 2001.
- Debt Assumption: Zimmer assumed $290 million borrowed by Bristol-Myers Squibb on August 2, 2001, and an additional $22 million on August 6, 2001, for which Zimmer receives no proceeds.
- Working Capital Borrowing: Zimmer borrowed approximately $140 million on August 2, 2001. Approximately $90 million satisfied inter-company obligations to Bristol-Myers Squibb, and $50 million was retained as working capital.
- Future Borrowing Capacity: Zimmer may borrow up to an additional $48 million to fund separation costs and up to $100 million for capital expenditures and working capital post-distribution.
- Projected Shares Outstanding: Approximately 193,760,191 shares of common stock are expected to be outstanding immediately following the distribution.
Material Changes
The primary material change is the corporate separation from Bristol-Myers Squibb, resulting in:
- Board Composition: Appointment of four new directors (John L. McGoldrick, Regina E. Herzlinger, Augustus A. White, III, and Larry C. Glasscock) and the designation of J. Raymond Elliott as Chairman of the Board.
- Debt Structure: Transition from a parent-guaranteed structure to an independent unsecured credit facility with customary covenants and guarantees by Zimmer and its domestic subsidiaries.
- Executive Compensation: Increase in the aggregate economic value of stock option awards to executive officers from $9,525,000 to $12,460,000 to reflect the separation.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, revenue projections, or management commentary on future operating performance. Key contingencies and risks identified include:
- Debt Covenants: The new credit agreement contains customary restrictions, covenants, and events of default for unsecured financing.
- Change of Control Provisions: The Stock Plan for Non-Employee Directors includes accelerated vesting provisions if a change of control occurs (defined as a 20% ownership change, merger, or majority board change) followed by involuntary termination.
- Separation Costs: The company anticipates incurring costs and expenses related to the separation, for which it has reserved borrowing capacity.
Investor Verification Checklist
- Verify the specific terms and covenants of the $600 million credit facility in Exhibit 10.1.
- Confirm the final number of shares outstanding and the trading ticker symbol following the August 6, 2001 distribution.
- Review the detailed vesting schedules and exercise prices for the increased executive option awards.
- Assess the impact of the $312 million in assumed and new debt on the company's initial leverage ratios.
- Examine the "Information Statement" referenced in the filing for full details on the adopted employee benefit plans.